Marketers using phony news sites and making deceptive claims to sell health-related products without disclosing that their commercial messages are advertisements, rather than objective journalism, would be required to refrain from deception and misleading statements, according to six consent judgments entered in four district courts (FTC v. Labra; FTC v. Ambervine Marketing LLC; FTC v. Vaughn; FTC v. Lee; FTC v. Dunlevy; FTC v. DLXM LLC).
The defendants were discovered during an investigation, conducted last year, targeting marketers who allegedly used fake news sites to promote weight-loss products. The Federal Trade Commission filed ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.